Mostrar el registro sencillo del ítem

dc.contributor.authorAkram, Ahsan R
dc.contributor.authorChankeshwara, Sunay V
dc.contributor.authorScholefield, Emma
dc.contributor.authorAslam, Tashfeen
dc.contributor.authorMcDonald, Neil
dc.contributor.authorMegía Fernández, Alicia 
dc.contributor.authorMarshall, Adam
dc.contributor.authorMills, Bethany
dc.contributor.authorAvlonitis, Nicolaos
dc.contributor.authorCraven, Thomas H
dc.contributor.authorSmyth, Annya M
dc.contributor.authorCollie, David S
dc.contributor.authorGray, Calum
dc.contributor.authorHirani, Nik
dc.contributor.authorHill, Adam T
dc.contributor.authorGovan, John R
dc.contributor.authorWalsh, Timothy
dc.contributor.authorHaslett, Christopher
dc.contributor.authorBradley, Mark
dc.contributor.authorDhaliwal, Kevin
dc.date.accessioned2024-01-29T09:04:17Z
dc.date.available2024-01-29T09:04:17Z
dc.date.issued2018
dc.identifier.citationSci. Transl. Med. 10, eaal0033 (2018)es_ES
dc.identifier.urihttps://hdl.handle.net/10481/87432
dc.descriptionAcknowledgment to AAAS for publishing this manuscript with DOI 10.1126/scitranslmed.aal0033 https://www.science.org/doi/10.1126/scitranslmed.aal0033es_ES
dc.description.abstractRespiratory infections in mechanically ventilated patients caused by Gram-negative bacteria are a major cause of morbidity. Rapid and unequivocal determination of the presence, localization, and abundance of bacteria is criti cal for positive resolution of the infections and could be used for patient stratification and for monitoring treat ment efficacy. Here, we developed an in situ approach to visualize Gram-negative bacterial species and cellular infiltrates in distal human lungs in real time. We used optical endomicroscopy to visualize a water-soluble optical imaging probe based on the antimicrobial peptide polymyxin conjugated to an environmentally sensitive fluoro phore. The probe was chemically stable and nontoxic and, after in-human intrapulmonary microdosing, enabled the specific detection of Gram-negative bacteria in distal human airways and alveoli within minutes. The results suggest that pulmonary molecular imaging using a topically administered fluorescent probe targeting bacterial lipid A is safe and practical, enabling rapid in situ identification of Gram-negative bacteria in humans.es_ES
dc.description.sponsorshipThis work was supported by Wellcome Trust, the Department of Health Healthcare Innovation Challenge Fund (HICF-0510-069), and the Engineering and Physical Sciences Research Council Interdisciplinary Research Collaboration “Proteus” (EP/K03197X/1). The GMP activities were supported by the National Institute for Health Research (NIHR) BRC GMP Unit at Guy’s and St. Thomas’ NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Association for the Advancement of Sciencees_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGram negative bacteriaes_ES
dc.subjectOptical imaginges_ES
dc.subjectFluorescence es_ES
dc.titleIn situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid Aes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1126/scitranslmed.aal0033
dc.type.hasVersionSMURes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional